Cargando…
Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii
Correction for ‘Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii’ by Sajal Kumar Halder et al., RSC Adv., 2022, 12, 24319–24338, https://doi.org/10.1039/D2RA02939A.
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465633/ https://www.ncbi.nlm.nih.gov/pubmed/36199598 http://dx.doi.org/10.1039/d2ra90089k |
_version_ | 1784787842209153024 |
---|---|
author | Halder, Sajal Kumar Mim, Maria Mulla Alif, Md. Meharab Hassan Shathi, Jannatul Fardous Alam, Md. Nuhu Shil, Aparna Himel, Mahbubul Kabir |
author_facet | Halder, Sajal Kumar Mim, Maria Mulla Alif, Md. Meharab Hassan Shathi, Jannatul Fardous Alam, Md. Nuhu Shil, Aparna Himel, Mahbubul Kabir |
author_sort | Halder, Sajal Kumar |
collection | PubMed |
description | Correction for ‘Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii’ by Sajal Kumar Halder et al., RSC Adv., 2022, 12, 24319–24338, https://doi.org/10.1039/D2RA02939A. |
format | Online Article Text |
id | pubmed-9465633 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Royal Society of Chemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-94656332022-10-04 Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii Halder, Sajal Kumar Mim, Maria Mulla Alif, Md. Meharab Hassan Shathi, Jannatul Fardous Alam, Md. Nuhu Shil, Aparna Himel, Mahbubul Kabir RSC Adv Chemistry Correction for ‘Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii’ by Sajal Kumar Halder et al., RSC Adv., 2022, 12, 24319–24338, https://doi.org/10.1039/D2RA02939A. The Royal Society of Chemistry 2022-09-12 /pmc/articles/PMC9465633/ /pubmed/36199598 http://dx.doi.org/10.1039/d2ra90089k Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/ |
spellingShingle | Chemistry Halder, Sajal Kumar Mim, Maria Mulla Alif, Md. Meharab Hassan Shathi, Jannatul Fardous Alam, Md. Nuhu Shil, Aparna Himel, Mahbubul Kabir Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii |
title | Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii |
title_full | Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii |
title_fullStr | Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii |
title_full_unstemmed | Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii |
title_short | Correction: Oxa-376 and Oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of Acinetobacter baumannii |
title_sort | correction: oxa-376 and oxa-530 variants of β-lactamase: computational study uncovers potential therapeutic targets of acinetobacter baumannii |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9465633/ https://www.ncbi.nlm.nih.gov/pubmed/36199598 http://dx.doi.org/10.1039/d2ra90089k |
work_keys_str_mv | AT haldersajalkumar correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii AT mimmariamulla correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii AT alifmdmeharabhassan correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii AT shathijannatulfardous correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii AT alammdnuhu correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii AT shilaparna correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii AT himelmahbubulkabir correctionoxa376andoxa530variantsofblactamasecomputationalstudyuncoverspotentialtherapeutictargetsofacinetobacterbaumannii |